Overslaan en naar de inhoud gaan

 Wetenschapelijke artikelen

Thromboembolism and Immune Checkpoint Blockade in Cancer Patients: An Old Foe for New Research.

Auteurs : Langouo Fontsa M, Aiello MM, Migliori E, Scartozzi M, Lambertini M, Willard-Gallo K, Solinas C
Jaar : 2022
Journal : Target Oncol
Volume : 17
Pagina's : 497-505

Biomarkers and immunotherapy: where are we?

Auteurs : Langouo Fontsa M, Padonou F, Willard-Gallo K
Jaar : 2022
Journal : Curr Opin Oncol
Volume : 34
Pagina's : 579-586

A Rare Case of Hepatic Vanishing Bile Duct Syndrome Occurring after Combination Therapy with Nivolumab and Cabozantinib in a Patient with Renal Carcinoma.

Auteurs : Gourari K, Catherine J, Garaud S, Kerger J, Lepida A, Georgala A, Lebrun F, Gomez Galdon M, Gil T, Willard-Gallo K, Langouo Fontsa M
Jaar : 2022
Journal : Diagnostics (Basel)
Volume : 12

The impact of tumor cell metabolism on T cell-mediated immune responses and immuno-metabolic biomarkers in cancer.

Auteurs : Noël G, Langouo Fontsa M, Willard-Gallo K
Jaar : 2018
Journal : Semin Cancer Biol
Volume : 52
Pagina's : 66-74

An atypical presentation of bronchial adenocarcinoma.

Auteurs : Langouo Fontsa M, CsToth I, Berghmans T, Feoli F, Meert AP
Jaar : 2013
Journal : Rev Med Brux
Volume : 34(3)
Pagina's : 181-3

Sequential use of protein kinase inhibitors potentiates their toxicity to melanoma cells: A rationale to combine targeted drugs based on protein expression inhibition profiles.

Auteurs : Aftimos P, Wiedig M, Langouo Fontsa M, Awada A, Ghanem G, Journe F
Jaar : 2013
Journal : Int J Oncol
Volume : 43(3)
Pagina's : 919-26